Basf Corporation

Based in NJ

🤖

AI Overview

With $11.8M in lobbying spend across 32 quarterly filings, Basf Corporation is one of the biggest lobbying spenders in Washington. Their lobbying covers 25 issue areas. Active from 2018 to 2025.

$11.8M
Total Spend
8
Years Active
1
Firms Hired
10
Lobbyists Deployed
25
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2018$1.4M
2019$1.4M
2020$1.3M
2021$1.4M
2022$700K
2023$1.4M
2024$1.6M
2025$2.5M

Issues Lobbied

Lobbying Firms

Lobbyists

Government Agencies Targeted

These are the government entities that Basf Corporation disclosed contacting in their lobbying filings.

HOUSE OF REPRESENTATIVESSENATEU.S. Trade Representative (USTR)Commerce, Dept of (DOC)Environmental Protection Agency (EPA)Energy, Dept ofAgriculture, Dept of (USDA)Council on Environmental Quality (CEQ)Office of Management & Budget (OMB)U.S. Fish & Wildlife Service (USFWS)Homeland Security, Dept of (DHS)U.S. Coast Guard (USCG)Treasury, Dept ofState, Dept of (DOS)White House OfficeHousing & Urban Development, Dept of (HUD)Natl Economic Council (NEC)Surface Transportation Board (STB)Federal Trade Commission (FTC)Transportation, Dept of (DOT)+4 more
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Taxation, Manufacturing, Trade, Financial, Consumer Issues and 20 more

Tax Cuts and Jobs Act (H.R. 1). Implementation of specific provisions on corporate tax rates, interest deductibility, border adjustability, impact on U.S. subsidiaries of foreign-based entities

Open competition in pipe materials, H.R. 5310. Support for open competition to allow use of plastic materials in key infrastructure piping projects.

No legislation yet introduced. Support for development of trade treaties, specifically TTIP, and importance of NAFTA and seeking reasonable negotiation objectives in context of renegotiation of NAFTA

Proposals to expand the scope of review of the Committee for Foreign Investment in the United States (CFIUS)(H.R. 4311, S. 2098)

Implementation of the Sunscreen Innovation Act (PL-113-195). Renewal and improvement of the Sunscreen Innovation Act in context of possible reform of the Over-the-Counter drug process at FDA (no bill

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.